Anchor-IMPACT: A standardized microfluidic platform for high-throughput antiangiogenic drug screening

Biotechnol Bioeng. 2021 Jul;118(7):2524-2535. doi: 10.1002/bit.27765. Epub 2021 Apr 8.

Abstract

In vitro models are becoming more advanced to truly present physiological systems while enabling high-throughput screening and analysis. Organ-on-a-chip devices provide remarkable results through the reconstruction of a three-dimensional (3D) cellular microenvironment although they need to be further developed in terms of multiple liquid patterning principle, material properties, and scalability. Here we present a 3D anchor-based microfluidic injection-molded plastic array culture platform (Anchor-IMPACT) that enables selective, space-intensive patterning of hydrogels using anchor-island for high-throughput angiogenesis evaluation model. Anchor-IMPACT consists of a central channel and an anchor-island, integrating the array into an abbreviated 96-well plate format with a standard microscope slide size. The anchor-island enables selective 3D cell patterning without channel-to-channel contact or any hydrogel injection port using an anchor structure unlike conventional culture compartment. The hydrogel was patterned into defined regions by spontaneous capillary flow under hydrophilic conditions. We configured multiple cell patterning structures to investigate the angiogenic potency of colorectal cancer cells in Anchor-IMPACT and the morphological properties of the angiogenesis induced by the paracrine effect were evaluated. In addition, the efficacy of anticancer drugs against angiogenic sprouts was verified by following dose-dependent responses. Our results indicate that Anchor-IMPACT offers not only a model of high-throughput experimentation but also an advanced 3D cell culture platform and can significantly improve current in vitro models while providing the basis for developing predictive preclinical models for biopharmaceutical applications.

Keywords: angiogenesis; colorectal cancer; high-throughput screening; microfluidics; organ-on-a-chip.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Cell Line, Tumor
  • Drug Evaluation, Preclinical
  • Human Umbilical Vein Endothelial Cells / metabolism*
  • Humans
  • Lab-On-A-Chip Devices*
  • Microfluidic Analytical Techniques*
  • Neovascularization, Pathologic / drug therapy*
  • Neovascularization, Pathologic / metabolism

Substances

  • Angiogenesis Inhibitors